Dallas U.S. Attorney joins Bristol investigations
Executive Summary
The U.S. Attorney in the Northern District of Texas opens an investigation into Bristol-Myers Squibb's pricing and marketing practices, the company discloses in a Nov. 9 Securities & Exchange Commission filing. The Dallas prosecutor joins ongoing inquiries into Bristol by the U.S. Attorneys in Boston and Philadelphia, the Department of Justice Civil Division, the HHS Inspector General, the Office of Personnel Management Inspector General, the House Energy & Commerce Committee, the Senate Finance Committee and "several states"...
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.